GeoVax Labs (GOVX) Assets Average (2011 - 2026)
GeoVax Labs (GOVX) posted quarterly Assets Average of $5.5 million for Q2 2026, down 32.13% year-over-year from $8.1 million in Q2 2025, and down 15.98% quarter-over-quarter from $6.5 million in Q4 2025.
GeoVax Labs (GOVX) Assets Average (2011 - 2026) Analysis & Trends
GeoVax Labs (GOVX) has reported Assets Average for 16 consecutive years, with $5.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Assets Average fell 32.13% year-over-year to $5.5 million; the TTM figure through Jun 2026 stood at $5.5 million (down 32.13% YoY), while the FY2025 annual figure was $7.2 million, down 16.87% from the prior year.
- Assets Average slipped to $5.5 million in Q2 2026 per GOVX's latest filing, from $6.5 million in the prior quarter.
- Across five years, Assets Average topped out at $35.9 million in Q3 2022 and bottomed at $3.7 million in Q2 2024.
- Historically, Assets Average has averaged $15.2 million across 5 years, with a median of $9.6 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average surged 132.01% — and 2024, when it slumped 84.68%.
- GeoVax Labs' Assets Average stood at $35.0 million in 2022, then tumbled by 63.55% to $12.7 million in 2023, then declined by 24.39% to $9.6 million in 2024, then sank by 32.15% to $6.5 million in 2025, then declined by 15.98% to $5.5 million in 2026.
- Business Quant data shows GOVX's Assets Average at $5.5 million in Q2 2026, $6.5 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 19.82 Bn |
| 10 | GeoVax Labs | 2.92 Mn | -220,776.39 | - | 5.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.49 Mn |
| Dec 31, 2025 | 6.54 Mn |
| Sep 30, 2025 | 6.04 Mn |
| Jun 30, 2025 | 8.09 Mn |
| Mar 31, 2025 | 9.49 Mn |
| Dec 31, 2024 | 9.63 Mn |
| Sep 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 3.73 Mn |
| Mar 31, 2024 | 6.32 Mn |
| Dec 31, 2023 | 12.74 Mn |
| Sep 30, 2023 | 18.73 Mn |
| Jun 30, 2023 | 24.33 Mn |
| Mar 31, 2023 | 29.38 Mn |
| Dec 31, 2022 | 34.96 Mn |
| Sep 30, 2022 | 35.91 Mn |
| Jun 30, 2022 | 25.05 Mn |
| Mar 31, 2022 | 14.33 Mn |
| Dec 31, 2021 | 15.07 Mn |
| Sep 30, 2021 | 19.08 Mn |
| Jun 30, 2021 | 20.47 Mn |